| INTRODUC TI ON
Cancer is a significant comorbidity for people living with HIV and is likely to affect growing numbers. Cancers traditionally considered as AIDS-defining (Kaposi Sarcoma, Non-Hodgkins Lymphoma and cervical cancer) occur less frequently in the era of effective HIV treatment but their incidence remains more common in those living with HIV compared to those without (Franceschi et al, 2010) . In addition to these virally driven cancers, there is a growing incidence of more common cancers associated with lifestyle and ageing as people live longer (Lifson & Lando, 2012; Shepherd et al., 2016) . With nearly 100,000 people living with HIV and receiving care in the UK, and over 7,000 still undiagnosed (Nash, 2018) , it is inevitable that an increasing number of people living with HIV will engage with cancer services. It is therefore timely to explore their experiences in order to inform the ideal of appropriate patient-centred cancer care.
The experiences of a dual diagnosis of HIV and cancer are largely unexplored in the literature. The small number of studies that exist suggest that both conditions combined have a powerful impact and that stigma plays a key part in influencing an individual's sense of self, the way they behave and the social responses of others (Hainsworth, Shahmanesh, & Stevenson, 2018; Maboko & Mavundla, 2006; Dodds, 2008; Molefe & Duma, 2009 ). The impact of each condition on its own is described extensively in the literature.
Cancer is a potentially life-threatening condition with physically debilitating symptoms and often toxic treatments which can disrupt people's normal activities. It is, however, socially acceptable to talk about and is often framed as deserving of sympathy (Lupton, 2003) . This acceptability is complicated by social prohibitions that require cancer to be discussed in positive courageous terms, which downplay negativity and complexity (Reisfield & Wilson, 2004) .
HIV is now a condition that can be managed easily with a minimally disruptive treatment taken once a day and routinely managed with six monthly visits to the clinic for blood tests to monitor the immune system. Providing the treatment is adhered to, people with HIV can expect to have the same life expectancy as those without. Furthermore, the "Undetectable = Untransmittable" (U = U) consensus statement based on recent evidence (Cohen et al., 2016; Rodger et al., 2016) has provided a clear message that a person with sustained undetectable levels of HIV virus in their blood cannot transmit HIV to their partners. Moyer and Hardon (2014) have described a "normalisation" discourse in which various medical, policy and institutional discourses have aimed to reframe HIV as a chronic disease like any other because of all of these features that make it easy to manage in the present day. Yet tensions remain within this discourse in large part due to the persistence of HIV-related stigma within society. In people living with HIV, this is often combined with social and economic stressors and intersecting stigmas such as being gay or a migrant. (Deacon, Stephney, & Prosalendis, 2005; Flowers, 2010; Mazanderani & Paparini, 2015) .
With a growing population of people living with HIV who are ageing and more likely to engage with cancer services, it is currently important to explore their experiences of cancer care. The needs of this group are likely to be particularly complex due to their experience of stigma as outlined above. An interpretive approach, utilising qualitative research methods was adopted as the most appropriate to explore this complexity to provide the context and explanation for information requirements and for behaviour around presentation, diagnosis and adherence to treatment. This paper presents the findings of a study that explored the experiences of having both conditions, with a focus on the journey through cancer care from the perspectives of both patients and healthcare professionals.
| METHODS
We conducted a thematic analysis of narratives provided in in-depth, longitudinal interviews conducted between June 2015 and March 2017 by 17 people living with HIV who received treatment for cancer. We performed a separate thematic analysis of ethnographic observations including 27 hr of participant observation in seven sessions in a healthcare setting where participants received their cancer care and seven informal interviews with healthcare professionals providing this care during the same period. Common themes were then examined from the different perspectives. All data were collected from three sites in London. Ethical approval was obtained from NRES (15/LO/0230) on 18 March 2015, and research governance approval was obtained from the local sites.
| SAMPLE AND S TUDY DE S I G N

| Patient interviews
London sites were chosen owing to their large, diverse population of people living with HIV offering perspectives from those with a wide range of characteristics. Participants were included who had prior experience of care outside the capital including other countries, and this aspect of their experience was sought. For the patient interviews, we aimed to include as wide a range of participant characteristics as possible. This included different types of cancer, men and women, prior HIV diagnosis and synchronous diagnosis of HIV and cancer, and a range of countries of origin in order to represent the diversity of people living with HIV. See Table 1 for the demographic details. Participants were given information about the study and provided written consent. Interviews were semi-structured and informed by a topic guide developed and tested using input of patient representatives. The first interviews were arranged to coincide with the start of cancer treatment, and subsequent interviews were negotiated according to patient preferences, but aimed to capture the period at the end of and beyond cancer treatment in order to reflect any change over time. All audio recordings, field notes and transcription files were saved in an encrypted secure location on the university server separate from the consent forms and other identifying information.
| Focused ethnography
The participant observations were performed at two London sites and recorded in detailed field notes and reflections. A variety of settings were selected to include different types of cancer service and different treatment scenarios. These included observations of both staff and patient interactions and staff opinions which were sought in informal conversations. The settings fell into two broadly different categories: "specialist HIV services" where staff administering cancer treatment were also trained in HIV care and "oncology services" where staff were solely trained in cancer care. A total of 27 hr of observation was performed, and field notes were typed up within two hours of each visit in order to provide accurate and rich descriptive accounts. Details describing the observations conducted are provided in Table 2 .
Semi-structured interviews were also conducted with seven healthcare professionals as part of the focused ethnography. These were audio-recorded and transcribed. Interviewees were selected to provide a range of perspectives from staff involved in the care of people with a dual diagnosis of HIV and cancer who came from both general cancer services and specialist HIV services (see Table 3 ).
| Data analysis
The interview and observation data were analysed separately. A thematic analysis was used to analyse the interview, observation and field note data following a similar process to that outlined in Braun and Clarke (2006) . This process started with a thorough familiarisation with the data, re-listening to the audio recordings and re-reading the transcripts. Initial codes which were low inference and descriptive were generated to cover as much of the data as possible and managed using the software package NVivo v10 (QSR International, Melbourne, Australia). Material with similar content or properties was then sorted into descriptive thematic categories and then organised into broader themes and sub-themes (Spencer, 2003 (Spencer, , 2003 . This process was applied to the first interviews and observations, working closely with FS (a medical sociologist and experienced qualitative researcher) and
MS (an HIV clinician with research expertise in social science, clinical medicine and epidemiology) to ensure that it was rigorous and of good quality. Examples of outlying or negative cases that ran counter to emerging themes were sought out in order to refine the interpretation.
| RE SULTS
The patient interviews yielded a larger amount of rich and in-depth data than the focused ethnography, and this is reflected in the pres- Obviously, the impact of this HIV diagnosis in terms of their expectations for the future was very different from those diagnosed at a time when HIV could be managed effectively on one pill a day with the expectation of good health and normal life expectancy. This experience is different again from those who were told about their HIV and cancer at the same time in a synchronous diagnosis in a situation where they were acutely unwell and hospitalised. Three participants had this experience and for them their overwhelming concern at the time was the outcome of their cancer: A striking feature of the patients interviewed was their social isolation, and often the support they did have was dependent on their HIV diagnosis remaining a secret. Some of the healthcare professionals delivering cancer care freely admitted that they did not know much about HIV treatment or where to go to find out more. For staff accustomed to being experts in providing advice, this lack of knowledge could feel unfamiliar and be experienced as potentially undermining to their sense of professional status.
| Patients' lack of confidence that cancer
One nurse described this knowledge gap feeling like a loss of control: This lack of knowledge about HIV appeared to present more immediate problems for the nurses who were interviewed, rather than the doctors, as it had a more direct impact on their working day in tasks such as giving out medicines and explaining their purpose.
| Being the only person with HIV in the clinic
People living with HIV expressed a feeling of difference in the cancer clinic. The stigma associated with HIV could be layered with other stigmatising features such as being in a same sex relationship or being a migrant. This was alluded to within the study, for example when an African woman was offered a choice of straight-haired wigs or when a young man described cancer support services as prioritising older people:
When I asked for financial help…because I was a young person I felt kind of discriminated, like for the older person you could see all the attention there, I was young, so they said "you do it, you do it" (Male, 30′s, Prior HIV diagnosis, Participant Interview) This sense of difference extended into participants' experiences of cancer treatment itself. Some participants were troubled that there was a lack of experience and precedent in caring for people like them. Looking at existing evidence online about the outcomes of their particular cancer was frustrating because they did not feel it was possible to draw the same conclusions from studies based on people who did not have HIV. Two people in the study were undergoing treatment which they had been told was the first or second of its kind to be given to someone with HIV.
These two participants both independently used the term "guinea pig" to describe their management, a not entirely positive phrase which suggests they viewed their treatment as a kind of experimentation, possibly reinforcing their feelings of difference from others.
| Patients' beliefs that their HIV status denied them equitable cancer treatment
Some participants felt that their HIV status denied them access to treatment options which they believed would have been available if they were not HIV positive. 
| Fear about inadvertent disclosure of HIV status
This study demonstrated that many people with a dual diagnosis were constantly working extremely hard to manage information and keep their HIV status secret to avoid anticipated rejection:
this work took a huge emotional toll at the same time that they were experiencing a debilitating and disruptive cancer diagnosis.
The worry about disclosure was evident in some participants' views about involving the GP in their cancer care. The distrust that some had for GPs and their reluctance to engage with them was an area in which they felt different from other people with cancer. Participants talked about fears regarding confidentiality and lack of knowledge around HIV. One man described this reluctance as originating from a period when he was first diagnosed HIV positive and he was worried about the GP maintaining his confidentiality:
it sounds strange that you were going to your doctor and not telling him about this major thing but I just didn't have the confidence that it wouldn't get out (Male, 50's, Prior HIV diagnosis, Participant Interview) GP surgeries are located in local communities and attended by neighbours. For some participants, their GP was informed of their HIV status by default and without their explicit permission as part of the routine practice within cancer services of sending a discharge letter containing past medical history and these individuals perceived this as a source of difficulty.
In settings such as wards or day care units where cancer treatment was administered healthcare workers described "confusion and secrets" as a feature of some of their interactions with patients who did not want the visitors present at their side to know their HIV status. They did not always express empathy in relation to the patients' wishes to protect information but talked more in terms of the impact on their established working practices, such as in the giving out and explanation about medication in the presence of others. The pressure to protect patient confidentiality made staff feel worried and inhibited from talking freely to their patient whilst delivering cancer care and potentially hampering their ability to provide quality care. One nurse described a situation where complicated instructions in handover about people who did or did not know a patient's HIV status had the effect of closing down their communication with that patient completely:
It is made a point of in handover, they don't want anyone other than you know one or whoever, to know. And then often you wouldn't know who the person they would want to know is…..so I found myself not discussing anything really (Nurse, Haematology inpatient ward, Ethnography) The issues around disclosure were framed by healthcare professionals as undermining to their clinical actions and associated clinical safeguards, as one nurse described in relation to the safe administration of medication: (Male, 60's, prior HIV diagnosis, Participant Interview) The constant management of information about their HIV status required a lot of work by participants at a time when they were unwell, but it was felt essential as many were certain that disclosure would lead to a withdrawal of support; a potentially catastrophic consequence that some healthcare professionals did not always show an understanding of.
| D ISCUSS I ON: A UNI QUE CONVERG EN CE OF PRE SSURE S WITHIN THE " VIS IB LE" C AN CER AND THE " INVIS IB LE" HIV
Our study found that having two serious illnesses, one which is life- is a common exclusion criteria in cancer clinical trials. In a study looking at lymphoma patients who were HIV positive (Venturelli, Pria, Stegmann, Smith, & Bower, 2015) , it was found that there was no scientific or safety justification for excluding people living with HIV from most lymphoma clinical trials and no clear justification provided for the exclusion. It would seem from this study that the impact of this on patients who were aware that they were denied access was a reinforcement of otherness.
This study adds weight to findings within the literature which describe ongoing tensions within the HIV normalisation discourse (Flowers, 2010; Mazanderani & Paparini, 2015; Moyer & Hardon, 2014) and goes further by characterising these tensions within the cancer healthcare setting. It has been recognised in the literature that due to the complexity of the treatment and language, many cancer patients prefer less active participation in medical decisions (Ernst et al., 2011 ) and can experience "work" such as liaising between services and managing symptoms as a burden, particularly if they do not have a social support network (May et al., 2014) . There is an increasing focus on biologically stratified medicine in cancer, and it has been found that as the patient pathway becomes ever more complex, the result can be an experience of care which is more fragmented and less personal (Day, Coombes, Mcgrath-Lone, Schoenborn, & Ward, 2017) . This study showed that on top of this people felt responsible for aspects of their HIV management during their cancer treatment when they were physically unwell and often very isolated. Because some of the pressures, particularly those relating to disclosure, were not immediately obvious, they were not always recognised or fully understood by healthcare workers, particularly in oncology services where limited time often meant the main focus was a standardised safe journey through treatment delivery. Long-term HIV is a relatively new phenomenon, and many healthcare professionals have low levels of knowledge and familiarity with HIV, which has historically been treated entirely within specialist clinics. All this suggests that cancer and other specialists would benefit from demonstrating more empathy to the challenges of having stigmatising conditions such as HIV and better understanding the isolation and effort that is required of patients to manage information within a dual diagnosis. Any future interventions aimed at improving these experiences would need to acknowledge the shared social narrative around HIV and the powerful impact of stigma so that this burden is not carried by the patient alone.
| LIMITATI ON S OF THE S TUDY
The interviews and observations were conducted in London. It could therefore be argued that the findings do not easily translate to other geographical areas. However, interview participants had experience from other settings outside London that they brought into the interviews.
Longitudinal interviews were only possible with six participants owing to loss to follow-up and six people who died after their first interview. This highlights a unique feature of a sample group who might normally be hard to reach and allowed their voices to be heard.
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